These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 9076766)
1. 99Tcm-tetrofosmin scintigraphy in the evaluation of palpable breast masses. Adalet I; Demirkol MO; Müslümanoğlu M; Bozfakioğlu Y; Cantez S Nucl Med Commun; 1997 Feb; 18(2):118-21. PubMed ID: 9076766 [TBL] [Abstract][Full Text] [Related]
2. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions. Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of palpable breast masses with 99Tcm-MIBI: a comparative study with mammography and ultrasonography. Burak Z; Argon M; Memiş A; Erdem S; Balkan Z; Duman Y; Ustün EE; Erhan Y; Ozkiliç H Nucl Med Commun; 1994 Aug; 15(8):604-12. PubMed ID: 7970442 [TBL] [Abstract][Full Text] [Related]
4. (99)mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis. Spanu A; Dettori G; Nuvoli S; Porcu A; Falchi A; Cottu P; Solinas ME; Scanu AM; Chessa F; Madeddu G Eur J Nucl Med; 2001 Dec; 28(12):1781-94. PubMed ID: 11734916 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of 99Tcm-tetrofosmin scintimammography in palpable breast tumours. Batista JF; Solano ME; Oliva JP; Rodriguez JL; Gómez J; Stüsser RJ; Sánchez E Nucl Med Commun; 1997 Apr; 18(4):338-40. PubMed ID: 9170618 [TBL] [Abstract][Full Text] [Related]
6. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions. Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of technetium-99m tetrofosmin mammoscintigraphy as compared to mammography for detecting and differentiating palpable breast masses of young Taiwanese women. Hoi YJ; Hsieh JF; Tsai SC; Sun SS; Kao CH Anticancer Res; 2000; 20(3B):2061-4. PubMed ID: 10928152 [TBL] [Abstract][Full Text] [Related]
8. 99Tcm-MIBI mammoscintigraphy of breast masses: early and delayed imaging. Lu G; Shih WJ; Huang HY; Long MQ; Sun Q; Liu YH; Chou C Nucl Med Commun; 1995 Mar; 16(3):150-6. PubMed ID: 7770238 [TBL] [Abstract][Full Text] [Related]
9. Tc-99m tetrofosmin in breast carcinoma and axillary lymph node metastases: a comparative study with Tc-99m MIBI. Akçay MN; Akin Y; Karabağ B; Ozcan O; Oren D Clin Nucl Med; 1997 Dec; 22(12):832-4. PubMed ID: 9408644 [TBL] [Abstract][Full Text] [Related]
10. Tc-99m tetrofosmin scintigraphy as an adjunct to plain-film mammography in palpable breast lesions. Fenlon HM; Phelan N; Tierney S; Gorey T; Ennis JT Clin Radiol; 1998 Jan; 53(1):17-24. PubMed ID: 9464430 [TBL] [Abstract][Full Text] [Related]
11. 99Tcm-MIBI scintimammography in the evaluation of breast lesions and axillary involvement: a comparison with mammography and histopathological diagnosis. Arslan N; Oztürk E; Ilgan S; Urhan M; Karaçalioglu O; Pekcan M; Tufan T; Bayhan H Nucl Med Commun; 1999 Apr; 20(4):317-25. PubMed ID: 10319351 [TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-tetrofosmin in diagnosis of breast cancer and axillary lymph node involvement. Jaukovic LDj; Ajdinovic BZ; Jankovic ZD; Strbac M Nucl Med Rev Cent East Eur; 2006; 9(1):30-6. PubMed ID: 16791801 [TBL] [Abstract][Full Text] [Related]
13. Scintimammography with technetium-99m tetrofosmin in the diagnosis of breast cancer and lymph node metastases. Mansi L; Rambaldi PF; Procaccini E; Gregorio FD; Laprovitera A; Pecori B; Vecchio WD Eur J Nucl Med; 1996 Aug; 23(8):932-9. PubMed ID: 8753682 [TBL] [Abstract][Full Text] [Related]
14. Scintimammography using Tc-99m tetrofosmin. Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of palpable breast masses with color Doppler sonography and gray scale imaging. Wilkens TH; Burke BJ; Cancelada DA; Jatoi I J Ultrasound Med; 1998 Feb; 17(2):109-15. PubMed ID: 9527570 [TBL] [Abstract][Full Text] [Related]
16. 99m-Tc-tetrofosmin scintigraphy for the evaluation of suspicious palpable and non-palpable breast lesions. Obwegeser R; Berghammer P; Muellauer-Ertl S; Kubista E; Sinzinger H Breast Cancer Res Treat; 2000 Aug; 62(3):253-8. PubMed ID: 11072790 [TBL] [Abstract][Full Text] [Related]
17. 201Tl scintigraphy in the evaluation of palpable and nonpalpable breast lesions: correlation with mammography and ultrasonography. Vural G; Atasever T; Ozdemir A; Oznur I; Karabacak NI; Gökçora N; Işik S; Unlü M Nuklearmedizin; 1997 Dec; 36(8):282-8. PubMed ID: 17068879 [TBL] [Abstract][Full Text] [Related]
18. Comparison of 99Tcm-tetrofosmin with 201Tl and 131I in the detection of differentiated thyroid cancer metastases. Nishiyama Y; Yamamoto Y; Ono Y; Takahashi K; Nakano S; Satoh K; Ohkawa M; Tanabe M Nucl Med Commun; 2000 Oct; 21(10):917-23. PubMed ID: 11130332 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of palpable breast masses with 201Tl scintigraphy. Rebollo AC; Torres-Avisbal M; Espinosa JE; Diaz C; Vallejo JA; Pacheco C; Pera C; Mateo A Br J Radiol; 1995 Oct; 68(814):1052-7. PubMed ID: 7496703 [TBL] [Abstract][Full Text] [Related]
20. Detection of lung and chest tumours using 99Tcm-tetrofosmin: comparison with 201Tl. Arbab AS; Koizumi K; Toyama K; Arai T; Araki T Nucl Med Commun; 1998 Jul; 19(7):657-63. PubMed ID: 9853346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]